Most Recent

image: Gene Silencing Is Golden

Gene Silencing Is Golden

By | August 1, 2013

A beginner’s how-to on RNAi screening in mammalian cells

0 Comments

image: Name That Metabolite!

Name That Metabolite!

By | July 1, 2013

A guided tour through the metabolome

1 Comment

image: Suited to a T

Suited to a T

By | May 1, 2013

Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.

1 Comment

image: Buying Cell-Culture Products

Buying Cell-Culture Products

By | March 1, 2013

A survey of The Scientist readers reveals who buys cell-growth products from whom, and why.

0 Comments

image: Set It and Forget It

Set It and Forget It

By | March 1, 2013

A tour of three systems for automating cell culture

0 Comments

image: Creative Emulsification

Creative Emulsification

By | November 1, 2012

Enhancing data collection from emulsion PCR reactions: three case studies

0 Comments

image: Enter the Third Dimension

Enter the Third Dimension

By | September 1, 2012

Cell culture goes 3-D with devices that better mimic in vivo conditions.

2 Comments

image: Lipids in the Spotlight

Lipids in the Spotlight

By | August 1, 2012

A guide to studying lipids using mass spectrometry

0 Comments

image: Proteome Portraits

Proteome Portraits

By | August 1, 2012

Innovations in mass spectrometry are making quick, comprehensive, and easy proteome mapping more attainable than ever.

0 Comments

image: Move Over, Mother Nature

Move Over, Mother Nature

By | July 1, 2012

Synthetic biologists harness software to design genes and networks.

5 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham